Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cristina Cusin, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01MH102279 (FAVA, MAURIZIO) Sep 18, 2015 - Jun 30, 2021
    NIH
    Neurobiological Underpinnings of Placebo Response in Depression
    Role: Co-Principal Investigator
  2. R21MH095826 (CUSIN, CRISTINA) Jul 23, 2012 - Jun 30, 2016
    NIH
    Neurobiological Bases of Placebo Response in Major Depressive Disorder
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Murck H, Fava M, Cusin C, Chin-Fatt C, Trivedi M. Brain Ventricle and Choroid Plexus Morphology as Predictor of Treatment Response: Findings from the EMBARC Study. Res Sq. 2023 Mar 01. PMID: 36909585; PMCID: PMC10002825.
    Citations:    
  2. Feeney A, Hoeppner BB, Freeman MP, Flynn M, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, DeBattista C, Ionescu DF, Cusin C, Papakostas GI, Jha MK, Fava M. Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine Study. J Clin Psychiatry. 2022 11 14; 84(1). PMID: 36383742.
    Citations: 1     Fields:    Translation:Humans
  3. Mischoulon D, Dunlop BW, Kinkead B, Schettler PJ, Lamon-Fava S, Rakofsky JJ, Nierenberg AA, Clain AJ, Mletzko Crowe T, Wong A, Felger JC, Sangermano L, Ziegler TR, Cusin C, Fisher LB, Fava M, Rapaport MH. Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial. J Clin Psychiatry. 2022 08 22; 83(5). PMID: 36005883.
    Citations: 1     Fields:    Translation:HumansCells
  4. Iosifescu DV, Norton RJ, Tural U, Mischoulon D, Collins K, McDonald E, De Taboada L, Foster S, Cusin C, Yeung A, Clain A, Schoenfeld D, Hamblin MR, Cassano P. Very Low-Level Transcranial Photobiomodulation for Major Depressive Disorder: The ELATED-3 Multicenter, Randomized, Sham-Controlled Trial. J Clin Psychiatry. 2022 08 08; 83(5). PMID: 35950904.
    Citations:    Fields:    Translation:Humans
  5. Ang YS, Cusin C, Petibon Y, Dillon DG, Breiger M, Belleau EL, Normandin M, Schroder H, Boyden S, Hayden E, Levine MT, Jahan A, Meyer AK, Kang MS, Brunner D, Gelda SE, Hooker J, El Fakhri G, Fava M, Pizzagalli DA. A multi-pronged investigation of option generation using depression, PET and modafinil. Brain. 2022 06 03; 145(5):1854-1865. PMID: 35150243; PMCID: PMC9166534.
    Citations: 1     Fields:    Translation:Humans
  6. Jain FA, Chernyak SV, Nickerson LD, Morgan S, Schafer R, Mischoulon D, Bernard-Negron R, Nyer M, Cusin C, Ramirez Gomez L, Yeung A. Four-Week Mentalizing Imagery Therapy for Family Dementia Caregivers: A Randomized Controlled Trial with Neural Circuit Changes. Psychother Psychosom. 2022; 91(3):180-189. PMID: 35287133; PMCID: PMC9064903.
    Citations: 2     Fields:    Translation:Humans
  7. Sakurai H, Hoeppner B, Jain F, Foster S, Pedrelli P, Mischoulon D, Fava M, Cusin C. Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine Treatment. J Clin Psychopharmacol. 2022 Mar-Apr 01; 42(2):140-145. PMID: 35170480.
    Citations:    Fields:    Translation:Humans
  8. Curtiss JE, Mischoulon D, Fisher LB, Cusin C, Fedor S, Picard RW, Pedrelli P. Rising early warning signals in affect associated with future changes in depression: a dynamical systems approach. Psychol Med. 2021 Dec 23; 1-9. PMID: 34937601.
    Citations: 2     Fields:    
  9. Cusin C, Colloca L. Treatment-Resistant Depression-Resistant to Placebos as Well? JAMA Netw Open. 2021 09 01; 4(9):e2127952. PMID: 34559235.
    Citations:    Fields:    Translation:Humans
  10. Pedrelli P, Fedor S, Ghandeharioun A, Howe E, Ionescu DF, Bhathena D, Fisher LB, Cusin C, Nyer M, Yeung A, Sangermano L, Mischoulon D, Alpert JE, Picard RW. Monitoring Changes in Depression Severity Using Wearable and Mobile Sensors. Front Psychiatry. 2020; 11:584711. PMID: 33391050.
    Citations: 16     
  11. Sydnor VJ, Lyall AE, Cetin-Karayumak S, Cheung JC, Felicione JM, Akeju O, Shenton ME, Deckersbach T, Ionescu DF, Pasternak O, Cusin C, Kubicki M. Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine's antidepressant effects. Transl Psychiatry. 2020 12 15; 10(1):432. PMID: 33319774; PMCID: PMC7738670.
    Citations: 4     Fields:    Translation:Humans
  12. Ang YS, Bruder GE, Keilp JG, Rutherford A, Alschuler DM, Pechtel P, Webb CA, Carmody T, Fava M, Cusin C, McGrath PJ, Weissman M, Parsey R, Oquendo MA, McInnis MG, Cooper CM, Deldin P, Trivedi MH, Pizzagalli DA. Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. Psychol Med. 2022 10; 52(13):2441-2449. PMID: 33213541; PMCID: PMC7613805.
    Citations: 1     Fields:    Translation:Humans
  13. Olsen ST, Basu I, Bilge MT, Kanabar A, Boggess MJ, Rockhill AP, Gosai AK, Hahn E, Peled N, Ennis M, Shiff I, Fairbank-Haynes K, Salvi JD, Cusin C, Deckersbach T, Williams Z, Baker JT, Dougherty DD, Widge AS. Case Report of Dual-Site Neurostimulation and Chronic Recording of Cortico-Striatal Circuitry in a Patient With Treatment Refractory Obsessive Compulsive Disorder. Front Hum Neurosci. 2020; 14:569973. PMID: 33192400.
    Citations: 8     
  14. Sakurai H, Jain F, Foster S, Pedrelli P, Mischoulon D, Fava M, Cusin C. Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review. J Affect Disord. 2020 11 01; 276:660-666. PMID: 32871698.
    Citations: 4     Fields:    Translation:Humans
  15. Petibon Y, Alpert NM, Ouyang J, Pizzagalli DA, Cusin C, Fava M, El Fakhri G, Normandin MD. PET imaging of neurotransmission using direct parametric reconstruction. Neuroimage. 2020 11 01; 221:117154. PMID: 32679252.
    Citations: 1     Fields:    Translation:HumansCells
  16. Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T, Dougherty DD, Schoenfeld DA, Fisher L, Cusin C, Dording C, Trinh NH, Pedrelli P, Yeung A, Farabaugh A, Papakostas GI, Chang T, Shapero BG, Chen J, Cassano P, Hahn EM, Rao EM, Brady RO, Singh RJ, Tyrka AR, Price LH, Fava M, Miller KK. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. Am J Psychiatry. 2020 10 01; 177(10):965-973. PMID: 32660299; PMCID: PMC7748292.
    Citations: 6     Fields:    Translation:Humans
  17. Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI. Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry. 2020 07; 25(7):1604. PMID: 30617276.
    Citations: 3     Fields:    
  18. Dichtel LE, Nyer M, Dording C, Fisher LB, Cusin C, Shapero BG, Pedrelli P, Kimball AS, Rao EM, Mischoulon D, Fava M, Miller KK. Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study. J Clin Psychiatry. 2020 06 09; 81(4). PMID: 32558402.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  19. Gliklich RE, Leavy MB, Cosgrove L, Simon GE, Gaynes BN, Peterson LE, Olin B, Cole C, DePaulo JR, Wang P, Crowe CM, Cusin C, Nix M, Berliner E, Trivedi MH. Harmonized Outcome Measures for Use in Depression Patient Registries and Clinical Practice. Ann Intern Med. 2020 06 16; 172(12):803-809. PMID: 32422056.
    Citations: 8     Fields:    Translation:Humans
  20. Freeman MP, Hock RS, Papakostas GI, Judge H, Cusin C, Mathew SJ, Sanacora G, Iosifescu DV, DeBattista C, Trivedi MH, Fava M. Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder. J Clin Psychopharmacol. 2020 May/Jun; 40(3):287-292. PMID: 32332464; PMCID: PMC7185034.
    Citations: 4     Fields:    Translation:Humans
  21. Jha MK, Fava M, Minhajuddin A, Chin Fatt C, Mischoulon D, Wakhlu N, Trombello JM, Cusin C, Trivedi MH. Anger attacks are associated with persistently elevated irritability in MDD: findings from the EMBARC study. Psychol Med. 2021 06; 51(8):1355-1363. PMID: 32138798.
    Citations: 3     Fields:    Translation:Humans
  22. Cusin C, Sakurai H, Bentley K, Pedrelli P, Foster S, Fava M, Mischoulon D. All Suicidal Ideation Is Not Created Equal: Two Cases of Suicide Attempts During Maintenance Ketamine Treatment. Am J Psychiatry. 2020 02 01; 177(2):173-174. PMID: 32008389.
    Citations: 1     Fields:    Translation:Humans
  23. Kimball A, Dichtel LE, Nyer MB, Mischoulon D, Fisher LB, Cusin C, Dording CM, Trinh NH, Yeung A, Haines MS, Sung JC, Pinna G, Rasmusson AM, Carpenter LL, Fava M, Klibanski A, Miller KK. The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause. Psychoneuroendocrinology. 2020 02; 112:104512. PMID: 31780185.
    Citations: 6     Fields:    Translation:Humans
  24. Sakurai H, L Carpenter L, R Tyrka A, Price LH, I Papakostas G, Dording CM, Yeung AS, Cusin C, Ludington E, Bernard-Negron R, Fava M, Mischoulon D. Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder. J Affect Disord. 2020 02 01; 262:118-125. PMID: 31733455.
    Citations: 4     Fields:    Translation:Humans
  25. Salloum NC, Fava M, Hock RS, Freeman MP, Flynn M, Hoeppner B, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression. J Affect Disord. 2020 01 01; 260:131-139. PMID: 31494365.
    Citations: 12     Fields:    Translation:Humans
  26. Sakurai H, Dording C, Yeung A, Foster S, Jain F, Chang T, Trinh NH, Bernard R, Boyden S, Iqbal SZ, Wilkinson ST, Mathew SJ, Mischoulon D, Fava M, Cusin C. Longer-term open-label study of adjunctive riluzole in treatment-resistant depression. J Affect Disord. 2019 11 01; 258:102-108. PMID: 31400624.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  27. Köhler-Forsberg O, Cusin C, Nierenberg AA. Evolving Issues in the Treatment of Depression. JAMA. 2019 Jun 25; 321(24):2401-2402. PMID: 31125042.
    Citations: 4     Fields:    Translation:Humans
  28. Freeman MP, Papakostas GI, Hoeppner B, Mazzone E, Judge H, Cusin C, Mathew S, Sanacora G, Iosifescu D, DeBattista C, Trivedi MH, Fava M. Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression. J Psychiatr Res. 2019 03; 110:166-171. PMID: 30641350.
    Citations: 20     Fields:    Translation:Humans
  29. Salloum NC, Fava M, Freeman MP, Flynn M, Hoeppner B, Hock RS, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression. Depress Anxiety. 2019 03; 36(3):235-243. PMID: 30597688.
    Citations: 9     Fields:    Translation:Humans
  30. Ionescu DF, Felicione JM, Gosai A, Cusin C, Shin P, Shapero BG, Deckersbach T. Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature. Harv Rev Psychiatry. 2018 Nov/Dec; 26(6):320-339. PMID: 29465479.
    Citations: 27     Fields:    Translation:Humans
  31. Cassano P, Petrie SR, Mischoulon D, Cusin C, Katnani H, Yeung A, De Taboada L, Archibald A, Bui E, Baer L, Chang T, Chen J, Pedrelli P, Fisher L, Farabaugh A, Hamblin MR, Alpert JE, Fava M, Iosifescu DV. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial. Photomed Laser Surg. 2018 Dec; 36(12):634-646. PMID: 30346890.
    Citations: 13     Fields:    Translation:Humans
  32. Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry. 2020 07; 25(7):1592-1603. PMID: 30283029; PMCID: PMC6447473.
    Citations: 85     Fields:    Translation:Humans
  33. Ionescu DF, Bentley KH, Eikermann M, Taylor N, Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, Cusin C. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. J Affect Disord. 2019 01 15; 243:516-524. PMID: 30286416.
    Citations: 44     Fields:    Translation:Humans
  34. Iovieno N, Shelton RC, Petrie SR, Cusin C, Fava M, Papakostas GI. Efficacy of Ziprasidone Augmentation of Escitalopram for Cognitive Symptoms of Major Depressive Disorder. J Clin Psychiatry. 2018 Jan/Feb; 79(1). PMID: 28749091.
    Citations: 1     Fields:    Translation:Humans
  35. Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. J Affect Disord. 2018 02; 227:198. PMID: 29100152.
    Citations:    Fields:    
  36. Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, Papakostas GI. Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD). Brain Stimul. 2018 Jan - Feb; 11(1):75-84. PMID: 29030111.
    Citations: 6     Fields:    Translation:Humans
  37. Ionescu DF, Cusin C. Drs Ionescu and Cusin Reply. J Clin Psychiatry. 2017 01; 78(1):e72. PMID: 28129501.
    Citations:    Fields:    
  38. Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, Eikermann M, Durham K, Swee MB, Chang T, Dording C, Soskin D, Kelley J, Mischoulon D, Brown EN, Fava M. Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation. Aust N Z J Psychiatry. 2017 Jan; 51(1):55-64. PMID: 26893373.
    Citations: 26     Fields:    Translation:Humans
  39. Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. J Affect Disord. 2017 Jan 15; 208:6-14. PMID: 27736689.
    Citations: 13     Fields:    Translation:Humans
  40. Mirzakhani H, Guchelaar HJ, Welch CA, Cusin C, Doran ME, MacDonald TO, Bittner EA, Eikermann M, Nozari A. Minimum Effective Doses of Succinylcholine and Rocuronium During Electroconvulsive Therapy: A Prospective, Randomized, Crossover Trial. Anesth Analg. 2016 09; 123(3):587-96. PMID: 26967896.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  41. Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study. J Clin Psychiatry. 2016 06; 77(6):e719-25. PMID: 27232360.
    Citations: 38     Fields:    Translation:Humans
  42. Dougherty DD, Chou T, Corse AK, Arulpragasam AR, Widge AS, Cusin C, Evans KC, Greenberg BD, Haber SN, Deckersbach T. Acute deep brain stimulation changes in regional cerebral blood flow in obsessive-compulsive disorder. J Neurosurg. 2016 11; 125(5):1087-1093. PMID: 26894459; PMCID: PMC9884519.
    Citations: 15     Fields:    Translation:Humans
  43. Ionescu DF, Fava M, Kim DJ, Baer L, Shelton RC, Cusin C. A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder. Ther Adv Psychopharmacol. 2016 Feb; 6(1):4-12. PMID: 26913173; PMCID: PMC4749740.
    Citations:    
  44. Cassano P, Trinh NH, Chang T, Cusin C, Fisher L, Pedrelli P, Nyer M, Kim DJ, Alpert J, Mischoulon D. Treatment Outcome in Depressed Latinos Predicted by Concomitant Psychosislike Symptoms. J Nerv Ment Dis. 2015 Oct; 203(10):769-73. PMID: 26356091.
    Citations:    Fields:    Translation:Humans
  45. Widge AS, Licon E, Zorowitz S, Corse A, Arulpragasam AR, Camprodon JA, Cusin C, Eskandar EN, Deckersbach T, Dougherty DD. Predictors of Hypomania During Ventral Capsule/Ventral Striatum Deep Brain Stimulation. J Neuropsychiatry Clin Neurosci. 2016; 28(1):38-44. PMID: 26404172.
    Citations: 15     Fields:    Translation:Humans
  46. Mischoulon D, De Jong MF, Vitolo OV, Cusin C, Dording CM, Yeung AS, Durham K, Parkin SR, Fava M, Dougherty DD. Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study. J Psychiatr Res. 2015 Nov; 70:98-105. PMID: 26424428.
    Citations: 3     Fields:    Translation:Humans
  47. Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV. Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study. Psychiatry J. 2015; 2015:352979. PMID: 26356811; PMCID: PMC4556873.
    Citations: 27     
  48. Iscan Z, Jin TB, Kendrick A, Szeglin B, Lu H, Trivedi M, Fava M, McGrath PJ, Weissman M, Kurian BT, Adams P, Weyandt S, Toups M, Carmody T, McInnis M, Cusin C, Cooper C, Oquendo MA, Parsey RV, DeLorenzo C. Test-retest reliability of freesurfer measurements within and between sites: Effects of visual approval process. Hum Brain Mapp. 2015 Sep; 36(9):3472-85. PMID: 26033168.
    Citations: 75     Fields:    Translation:Humans
  49. Dillon DG, Wiecki T, Pechtel P, Webb C, Goer F, Murray L, Trivedi M, Fava M, McGrath PJ, Weissman M, Parsey R, Kurian B, Adams P, Carmody T, Weyandt S, Shores-Wilson K, Toups M, McInnis M, Oquendo MA, Cusin C, Deldin P, Bruder G, Pizzagalli DA. A computational analysis of flanker interference in depression. Psychol Med. 2015 Aug; 45(11):2333-44. PMID: 25727375.
    Citations: 17     Fields:    Translation:Humans
  50. Diaz-Gil D, Mueller N, Moreno-Duarte I, Lin H, Ayata C, Cusin C, Cotten JF, Eikermann M. Etomidate and Ketamine: Residual Motor and Adrenal Dysfunction that Persist beyond Recovery from Loss of Righting Reflex in Rats. Pharmaceuticals (Basel). 2014 Dec 29; 8(1):21-37. PMID: 25551398; PMCID: PMC4381199.
    Citations: 3     
  51. Dougherty DD, Rezai AR, Carpenter LL, Howland RH, Bhati MT, O'Reardon JP, Eskandar EN, Baltuch GH, Machado AD, Kondziolka D, Cusin C, Evans KC, Price LH, Jacobs K, Pandya M, Denko T, Tyrka AR, Brelje T, Deckersbach T, Kubu C, Malone DA. A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression. Biol Psychiatry. 2015 Aug 15; 78(4):240-8. PMID: 25726497.
    Citations: 144     Fields:    Translation:HumansCTClinical Trials
  52. Chen JA, Vijapura S, Papakostas GI, Parkin SR, Kim DJ, Cusin C, Baer L, Clain AJ, Fava M, Mischoulon D. Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group. Asian J Psychiatr. 2015 Feb; 13:23-9. PMID: 25544195.
    Citations: 5     Fields:    Translation:HumansAnimals
  53. Pedrelli P, Nyer M, Holt D, Bakow BR, Fava M, Baer L, Cassiello C, Mulligan M, Cusin C, Farabaugh A. Correlates of irritability in college students with depressive symptoms. J Nerv Ment Dis. 2013 Nov; 201(11):953-8. PMID: 24177482; PMCID: PMC4524561.
    Citations: 8     Fields:    Translation:Humans
  54. Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ, Perlis RH. A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. J Clin Psychiatry. 2013 Jul; 74(7):e636-41. PMID: 23945458.
    Citations: 23     Fields:    Translation:Humans
  55. Cusin C, Franco FB, Fernandez-Robles C, DuBois CM, Welch CA. Rapid improvement of depression and psychotic symptoms in Huntington's disease: a retrospective chart review of seven patients treated with electroconvulsive therapy. Gen Hosp Psychiatry. 2013 Nov-Dec; 35(6):678.e3-5. PMID: 23541803.
    Citations: 8     Fields:    Translation:Humans
  56. Cusin C, Dougherty DD. Correction: Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biol Mood Anxiety Disord. 2013 Jan 01; 3(1):1. PMID: 23276307.
    Citations:    
  57. Cusin C, Dougherty DD. Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biol Mood Anxiety Disord. 2012 08 17; 2:14. PMID: 22901565.
    Citations: 24     
  58. Kelley JM, Kaptchuk TJ, Cusin C, Lipkin S, Fava M. Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychother Psychosom. 2012; 81(5):312-4. PMID: 22854752.
    Citations: 68     Fields:    Translation:Humans
  59. Cusin C, Hilton GQ, Nierenberg AA, Fava M. Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression. Am J Psychiatry. 2012 Aug; 169(8):868-9. PMID: 22854933.
    Citations: 16     Fields:    Translation:Humans
  60. Perlis RH, Cusin C, Fava M. Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder. Psychol Med. 2014 May; 44(7):1361-7. PMID: 22417535.
    Citations: 6     Fields:    Translation:Humans
  61. Quinn DK, McGahee SM, Politte LC, Duncan GN, Cusin C, Hopwood CJ, Stern TA. Complications of carbon monoxide poisoning: a case discussion and review of the literature. Prim Care Companion J Clin Psychiatry. 2009; 11(2):74-9. PMID: 19617936.
    Citations: 6     
  62. Perlis RH, Purcell S, Fagerness J, Cusin C, Yamaki L, Fava M, Smoller JW. Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder. Biol Psychiatry. 2007 Sep 01; 62(5):536-40. PMID: 17300755.
    Citations: 19     Fields:    Translation:Humans
  63. Perlis RH, Beasley CM, Wines JD, Tamura RN, Cusin C, Shear D, Amsterdam J, Quitkin F, Strong RE, Rosenbaum JF, Fava M. Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes. Psychother Psychosom. 2007; 76(1):40-6. PMID: 17170562.
    Citations: 26     Fields:    Translation:Humans
  64. Cusin C, Fava M, Amsterdam JD, Quitkin FM, Reimherr FW, Beasley CM, Rosenbaum JF, Perlis RH. Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications. J Clin Psychiatry. 2007 Jan; 68(1):52-7. PMID: 17284130.
    Citations: 5     Fields:    Translation:Humans
  65. Serretti A, Cusin C, Rausch JL, Bondy B, Smeraldi E. Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis. Psychiatry Res. 2006 Nov 29; 145(1):61-5. PMID: 17069894.
    Citations: 8     Fields:    Translation:HumansCells
  66. Serretti A, Cusin C, Benedetti F, Mandelli L, Pirovano A, Zanardi R, Colombo C, Smeraldi E. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet. 2005 Aug 05; 137B(1):36-9. PMID: 15952199.
    Citations: 38     Fields:    Translation:Humans
  67. Galili-Weisstub E, Levy S, Frisch A, Gross-Tsur V, Michaelovsky E, Kosov A, Meltzer A, Goltser T, Serretti A, Cusin C, Darvasi A, Inbar E, Weizman A, Segman RH. Dopamine transporter haplotype and attention-deficit hyperactivity disorder. Mol Psychiatry. 2005 Jul; 10(7):617-8. PMID: 15940306.
    Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
  68. Cassano P, Soares CN, Cusin C, Mascarini A, Cohen LS, Fava M. Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine. Psychother Psychosom. 2005; 74(6):362-5. PMID: 16244512.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  69. Yang H, Cusin C, Fava M. Is there a placebo problem in antidepressant trials? Curr Top Med Chem. 2005; 5(11):1077-86. PMID: 16181132.
    Citations: 9     Fields:    Translation:Humans
  70. Serretti A, Cusin C, Rossini D, Artioli P, Dotoli D, Zanardi R. Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders. Am J Med Genet B Neuropsychiatr Genet. 2004 Aug 15; 129B(1):36-40. PMID: 15274037.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  71. Serretti A, Artioli P, Zanardi R, Lorenzi C, Rossini D, Cusin C, Arnoldi A, Catalano M. Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder. Psychopharmacology (Berl). 2004 Aug; 174(4):504-11. PMID: 15248044.
    Citations: 11     Fields:    Translation:HumansCells
  72. Zanardi R, Cusin C, Rossini D, De Ronchi D, Serretti A. Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression. J Clin Psychopharmacol. 2003 Dec; 23(6):535-9. PMID: 14624182.
    Citations: 4     Fields:    Translation:Humans
  73. Serretti A, Cusin C, Cristina S, Lorenzi C, Lilli R, Lattuada E, Grieco G, Costa A, Santorelli F, Barale F, Smeraldi E, Nappi G. Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders. Psychiatr Genet. 2003 Jun; 13(2):121-6. PMID: 12782971.
    Citations: 3     Fields:    Translation:HumansCells
  74. Serretti A, Lorenzi C, Cusin C, Zanardi R, Lattuada E, Rossini D, Lilli R, Pirovano A, Catalano M, Smeraldi E. SSRIs antidepressant activity is influenced by G beta 3 variants. Eur Neuropsychopharmacol. 2003 Mar; 13(2):117-22. PMID: 12650956.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  75. Serretti A, Mandelli L, Lattuada E, Cusin C, Smeraldi E. Clinical and demographic features of mood disorder subtypes. Psychiatry Res. 2002 Nov 15; 112(3):195-210. PMID: 12450629.
    Citations: 13     Fields:    Translation:Humans
  76. Cusin C, Serretti A, Mandelli L, Lucca A, Smeraldi E. Seasonal variations of lithium plasma levels. Psychiatry Res. 2002 Aug 05; 111(1):35-41. PMID: 12140117.
    Citations: 1     Fields:    Translation:HumansCells
  77. Serretti A, Cristina S, Lilli R, Cusin C, Lattuada E, Lorenzi C, Corradi B, Grieco G, Costa A, Santorelli F, Barale F, Nappi G, Smeraldi E. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Am J Med Genet. 2002 May 08; 114(4):361-9. PMID: 11992558.
    Citations: 15     Fields:    Translation:Humans
  78. Cusin C, Serretti A, Lattuada E, Lilli R, Lorenzi C, Smeraldi E. Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. Am J Med Genet. 2002 May 08; 114(4):380-90. PMID: 11992560.
    Citations: 6     Fields:    Translation:Humans
  79. Cusin C, Serretti A, Zanardi R, Lattuada E, Rossini D, Lilli R, Lorenzi C, Smeraldi E. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. Int J Neuropsychopharmacol. 2002 Mar; 5(1):27-35. PMID: 12057029.
    Citations: 17     Fields:    Translation:HumansCTClinical Trials
  80. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E. Serotonin transporter gene (5-HTTLPR) and major psychoses. Mol Psychiatry. 2002; 7(1):95-9. PMID: 11803453.
    Citations: 14     Fields:    Translation:HumansCells
  81. Serretti A, Zanardi R, Cusin C, Rossini D, Lilli R, Lorenzi C, Lattuada E, Smeraldi E. No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors. Psychiatry Res. 2001 Nov 30; 104(3):195-203. PMID: 11728608.
    Citations: 8     Fields:    Translation:Humans
  82. Serretti A, Zanardi R, Cusin C, Rossini D, Lorenzi C, Smeraldi E. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. Eur Neuropsychopharmacol. 2001 Oct; 11(5):375-80. PMID: 11597824.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  83. Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Lattuada E, Dotoli D, Smeraldi E. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol Psychiatry. 2001 Sep 01; 50(5):323-30. PMID: 11543734.
    Citations: 32     Fields:    Translation:HumansCTClinical Trials
  84. Serretti A, Zanardi R, Rossini D, Cusin C, Lilli R, Smeraldi E. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol Psychiatry. 2001 Sep; 6(5):586-92. PMID: 11526473.
    Citations: 28     Fields:    Translation:HumansCTClinical Trials
  85. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E. Tryptophan hydroxylase gene and major psychoses. Psychiatry Res. 2001 Aug 05; 103(1):79-86. PMID: 11472792.
    Citations: 8     Fields:    Translation:Humans
  86. Cusin C, Serretti A, Lattuada E, Lilli R, Lorenzi C, Mandelli L, Pisati E, Smeraldi E. Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders. J Psychiatr Res. 2001 Jul-Aug; 35(4):217-23. PMID: 11578639.
    Citations: 7     Fields:    Translation:Humans
  87. Cusin C, Serretti A, Lattuada E, Mandelli L, Smeraldi E. Impact of clinical variables on illness time course in mood disorders. Psychiatry Res. 2000 Dec 27; 97(2-3):217-27. PMID: 11166092.
    Citations: 5     Fields:    Translation:Humans
  88. Serretti A, Macciardi F, Cusin C, Lattuada E, Souery D, Lipp O, Mahieu B, Van Broeckhoven C, Blackwood D, Muir W, Aschauer HN, Heiden AM, Ackenheil M, Fuchshuber S, Raeymaekers P, Verheyen G, Kaneva R, Jablensky A, Papadimitriou GN, Dikeos DG, Stefanis CN, Smeraldi E, Mendlewicz J. Linkage of mood disorders with D2, D3 and TH genes: a multicenter study. J Affect Disord. 2000 Apr; 58(1):51-61. PMID: 10760558.
    Citations: 3     Fields:    Translation:Humans
  89. Serretti A, Cusin C, Lorenzi C, Lattuada E, Lilli R, Smeraldi E. Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia. Am J Med Genet. 2000 Feb 07; 96(1):84-7. PMID: 10686558.
    Citations: 2     Fields:    Translation:HumansCells
  90. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E. Lack of association between tryptophan hydroxylase gene and psychotic symptomatology in schizophrenia. Schizophr Res. 1999 Nov 30; 40(2):171-2. PMID: 10593456.
    Citations: 2     Fields:    Translation:Humans
  91. Serretti A, Cusin C, Lattuada E, Lilli R, Lorenzi C, Di Bella D, Catalano M, Smeraldi E. No interaction between serotonin transporter gene and dopamine receptor D4 gene in symptomatology of major psychoses. Am J Med Genet. 1999 Oct 15; 88(5):481-5. PMID: 10490703.
    Citations: 1     Fields:    Translation:Humans
  92. Serretti A, Lattuada E, Cusin C, Lilli R, Lorenzi C, Smeraldi E. Dopamine D3 receptor gene not associated with symptomatology of major psychoses. Am J Med Genet. 1999 Oct 15; 88(5):476-80. PMID: 10490702.
    Citations: 1     Fields:    Translation:Humans
  93. Serretti A, Lattuada E, Cusin C, Gasperini M, Smeraldi E. Clinical and demographic features of psychotic and nonpsychotic depression. Compr Psychiatry. 1999 Sep-Oct; 40(5):358-62. PMID: 10509618.
    Citations: 7     Fields:    Translation:Humans
  94. Lattuada E, Serretti A, Cusin C, Gasperini M, Smeraldi E. Symptomatologic analysis of psychotic and non-psychotic depression. J Affect Disord. 1999 Jul; 54(1-2):183-7. PMID: 10403162.
    Citations: 13     Fields:    Translation:Humans
  95. Seretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E. Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry. 1999 May; 4(3):280-3. PMID: 10395220.
    Citations: 19     Fields:    Translation:HumansCells
  96. Serretti A, Lattuada E, Cusin C, Smeraldi E. Factor analysis of delusional disorder symptomatology. Compr Psychiatry. 1999 Mar-Apr; 40(2):143-7. PMID: 10080261.
    Citations: 7     Fields:    Translation:Humans
  97. Serretti A, Macciardi F, Cusin C, Lattuada E, Lilli R, Di Bella D, Catalano M, Smeraldi E. No interaction of GABA(A) alpha-1 subunit and dopamine receptor D4 exon 3 genes in symptomatology of major psychoses. Am J Med Genet. 1999 Feb 05; 88(1):44-9. PMID: 10050966.
    Citations: 2     Fields:    Translation:Humans
  98. Serretti A, Macciardi F, Cusin C, Lattuada E, Lilli R, Smeraldi E. Dopamine receptor D4 gene is associated with delusional symptomatology in mood disorders. Psychiatry Res. 1998 Aug 17; 80(2):129-36. PMID: 9754691.
    Citations: 2     Fields:    Translation:Humans
  99. Serretti A, Macciardi F, Verga M, Cusin C, Pedrini S, Smeraldi E. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. Am J Med Genet. 1998 Mar 28; 81(2):127-30. PMID: 9613850.
    Citations: 12     Fields:    Translation:Humans
  100. Serretti A, Macciardi F, Cusin C, Verga M, Pedrini S, Smeraldi E. Tyrosine hydroxylase gene in linkage disequilibrium with mood disorders. Mol Psychiatry. 1998 Mar; 3(2):169-74. PMID: 9577842.
    Citations: 4     Fields:    Translation:HumansCells
  101. Serretti A, Lattuada E, Cusin C, Macciardi F, Smeraldi E. Analysis of depressive symptomatology in mood disorders. Depress Anxiety. 1998; 8(2):80-5. PMID: 9784982.
    Citations: 4     Fields:    Translation:Humans
  102. Serretti A, Macciardi F, Cusin C, Lattuada E, Lilli R, Di Bella D, Catalano M, Smeraldi E. GABAA alpha-1 subunit gene not associated with depressive symptomatology in mood disorders. Psychiatr Genet. 1998; 8(4):251-4. PMID: 9861645.
    Citations: 4     Fields:    Translation:Humans
  103. Cusin C, Stuckelberger A, Vuilleumier J, Michel JP. [Discharge from a geriatric hospital: return home or placement in a home for the aged. Prospective study of factors forecasting the destination]. Rev Med Suisse Romande. 1991 Mar; 111(3):257-65. PMID: 2031126.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Cusin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (273)
Explore
_
Co-Authors (66)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.